Franklin Resources’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-14,166
| Closed | -$1.44M | – | 2825 |
|
|
2023
Q2 | $1.44M | Buy |
14,166
+11,259
| +387% | +$1.07M | ﹤0.01% | 1521 |
|
|
2023
Q1 | $264K | Buy |
+2,907
| New | +$171K | ﹤0.01% | 1906 |
|
|
2022
Q4 | – | Sell |
-294,889
| Closed | -$7.41M | – | 2402 |
|
|
2022
Q3 | $7.41M | Sell |
294,889
-338,767
| -53% | -$9.39M | ﹤0.01% | 1006 |
|
|
2022
Q2 | $19.3M | Sell |
633,656
-218,502
| -26% | -$6.52M | 0.01% | 807 |
|
|
2022
Q1 | $27.9M | Sell |
852,158
-105
| -0% | -$3.12K | 0.01% | 763 |
|
|
2021
Q4 | $22.5M | Sell |
852,263
-172,035
| -17% | -$13.3M | 0.01% | 860 |
|
|
2021
Q3 | $103M | Sell |
1,024,298
-363,662
| -26% | -$42.6M | 0.04% | 467 |
|
|
2021
Q2 | $196M | Sell |
1,387,960
-71,829
| -5% | -$8.11M | 0.08% | 294 |
|
|
2021
Q1 | $146M | Sell |
1,459,789
-2,138
| -0.1% | -$249K | 0.06% | 342 |
|
|
2020
Q4 | $181M | Buy |
1,461,927
+68,273
| +5% | +$8.97M | 0.08% | 284 |
|
|
2020
Q3 | $136M | Buy |
1,393,654
+60,573
| +5% | +$7.57M | 0.07% | 317 |
|
|
2020
Q2 | $213M | Buy |
1,333,081
+131,210
| +11% | +$19.9M | 0.11% | 224 |
|
|
2020
Q1 | $174M | Sell |
1,201,871
-41,260
| -3% | -$7.97M | 0.12% | 206 |
|
|
2019
Q4 | $254M | Sell |
1,243,131
-11,896
| -0.9% | -$2.17M | 0.13% | 192 |
|
|
2019
Q3 | $101M | Buy |
1,255,027
+96,297
| +8% | +$8.17M | 0.05% | 370 |
|
|
2019
Q2 | $109M | Buy |
1,158,730
+179,994
| +18% | +$15.5M | 0.06% | 354 |
|
|
2019
Q1 | $83.7M | Buy |
978,736
+17,437
| +2% | +$1.45M | 0.04% | 411 |
|
|
2018
Q4 | $53.9M | Buy |
961,299
+102,286
| +12% | +$6.24M | 0.03% | 473 |
|
|
2018
Q3 | $70.2M | Buy |
859,013
+593,552
| +224% | +$41.8M | 0.04% | 458 |
|
|
2018
Q2 | $9.28M | Buy |
265,461
+27
| +0% | +$822 | ﹤0.01% | 935 |
|
|
2018
Q1 | $5.44M | Hold |
265,434
| – | – | ﹤0.01% | 1032 |
|
|
2017
Q4 | $7.52M | Buy |
265,434
+15,392
| +6% | +$429K | ﹤0.01% | 998 |
|
|
2017
Q3 | $7.78M | Buy |
+250,042
| New | +$7.52M | ﹤0.01% | 1004 |
|
Other funds holding RETA
Franklin Resources's RETA Position: Q3 2023 in Review
Franklin Resources sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 14,166 shares — an estimated $1.44M sold.
Franklin Resources first reported a position in RETA in Q3 2017 and held it in 23 quarters. The position peaked at $254M in Q4 2019. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.
- Franklin Resources reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Franklin Resources sold 14,166 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.44M.
- Franklin Resources first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2017 and held it in 23 quarters.
- Franklin Resources's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $254M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.
Based on Franklin Resources's 13F filing for Q3 2023, filed 13 Nov 2023.